Skechers Performance UK Division Partners with Breast Cancer Care
Skechers Performance UK Releases a GOwalk 4™
Footwear Collection to support Breast Cancer Care
LONDON–(BUSINESS WIRE)–Skechers Performance UK Division, is thrilled to confirm their ongoing
partnership with Breast Cancer Care, to help support women across the UK
who are facing breast cancer. Skechers Performance UK will launch a
month-long marketing campaign that includes in-store, print and social
media activity. To re-launch the partnership, Skechers Performance UK
are releasing a new, limited edition GOwalk 4™ footwear collection
marked with the iconic breast cancer awareness pink ribbon, which will
be available in SKECHERS retail stores from the 7th April and
online April 1st, 2017.
“We are extremely proud to announce our continued partnership with
Breast Cancer Care,” said Peter Youell, SKECHERS UK & Ireland Managing
Director. “It is an important charity that provides significant care and
support for those affected by breast cancer. Following the success of
our first campaign, we wanted to further our support for the charity,
and with this new collaboration, we wish to continue building awareness
surrounding all the incredible work that Breast Cancer Care does. We are
pleased to play a role in supporting their incredible work providing
care, support and information to help thousands of people to find a way
to live with, through and beyond breast cancer.”
Lizzie Iredale, Head of Corporate Partnerships at Breast Cancer Care
added, “We are delighted that Skechers are continuing to support Breast
Cancer Care. The funds Skechers raise will help us to continue to
provide anyone affected by breast cancer with the best care, support and
information when they need it most.
“Every year around 62,000 people are diagnosed with Breast Cancer in the
UK, that’s around one person every ten minutes, so there’s never been
such an urgent need for our support services.”
The Skechers Performance Breast Cancer Care collection is available in
two Skechers GOwalk 4 styles, and will retail for £59.00. A donation of
£5 per pair sold will be donated to the charity. The designs incorporate
a black, white and charcoal colour pallet with the classic pink hue
weaved in. Each style also features the iconic pink ribbon detailing on
the heel. The Skechers GOwalk 4 shoes available in both slip-on and
lace-up styles and features the new Skechers Goga Max® insole
for the most advanced walking experience ever. The shoe also has
responsive flexibility for a more natural movement and incorporates Goga
Pillars™ for added comfort and a tapering midfoot for improved arch
support.
The limited edition Skechers Performance Breast Cancer Care line is
available at SKECHERS retail stores in the United Kingdom and online at Skechers.co.uk
throughout April. The funds raised will help Breast Cancer Care continue
to provide support for anyone affected by breast cancer.
For more information about breast cancer and the charity visit www.breastcancercare.org.uk.
To learn more about Skechers Performance visit www.skechers.co.uk
and follow us on Facebook (facebook.com/SkechersPerformanceUK),
Twitter (twitter.com/SKXPerformance)
ABOUT SKECHERS USA, INC.
SKECHERS USA, Inc., based in Manhattan Beach, California, designs,
develops and markets a diverse range of lifestyle footwear for men,
women and children, as well as performance footwear for men and women.
SKECHERS footwear is available in the United States and over 160
countries and territories worldwide via department and specialty stores,
more than 2,012 SKECHERS Company-owned and third-party-owned retail
stores, and the Company’s e-commerce websites. The Company manages its
international business through a network of global distributors, joint
venture partners in Asia and the Middle East, and wholly-owned
subsidiaries in Canada, Japan, throughout Europe and Latin America. For
more information, please visit skechers.com
and follow us on Facebook (facebook.com/SKECHERS)
and Twitter (twitter.com/SKECHERSUSA).
This announcement contains forward-looking statements that are made
pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. These forward-looking statements include,
without limitation, the Company’s future domestic and international
growth, financial results and operations including expected net sales
and earnings, its development of new products, future demand for its
products, its planned domestic and international expansion and opening
of new stores, and advertising and marketing initiatives.
Forward-looking statements can be identified by the use of
forward-looking language such as “believe,” “anticipate,” “expect,”
“estimate,” “intend,” “plan,” “project,” “will be,” “will continue,”
“will result,” “could,” “may,” “might,” or any variations of such words
with similar meanings. Any such statements are subject to risks and
uncertainties that could cause actual results to differ materially from
those projected in forward-looking statements. Factors that might cause
or contribute to such differences include international economic,
political and market conditions including the uncertainty of sustained
recovery in Europe; sustaining, managing and forecasting costs and
proper inventory levels; losing any significant customers; decreased
demand by industry retailers and cancellation of order commitments due
to the lack of popularity of particular designs and/or categories of
products; maintaining brand image and intense competition among sellers
of footwear for consumers, especially in the highly competitive
performance footwear market; anticipating, identifying, interpreting or
forecasting changes in fashion trends, consumer demand for the products
and the various market factors described above; sales levels during the
spring, back-to-school and holiday selling seasons; and other factors
referenced or incorporated by reference in the Company’s annual report
on Form 10-K for the year ended December 31, 2016. The risks included
here are not exhaustive. The Company operates in a very competitive and
rapidly changing environment. New risks emerge from time to time and the
companies cannot predict all such risk factors, nor can the companies
assess the impact of all such risk factors on their respective
businesses or the extent to which any factor, or combination of factors,
may cause actual results to differ materially from those contained in
any forward-looking statements. Given these risks and uncertainties, you
should not place undue reliance on forward-looking statements as a
prediction of actual results. Moreover, reported results should not be
considered an indication of future performance.
About Breast Cancer Care
When you have breast cancer, everything changes. Time becomes measured
in appointments. The next scan. The next results. The next challenge.
At Breast Cancer Care, we understand the emotions, challenges and
decisions you face every day. So, from the day you notice something’s
not right to the day you begin to move forward, we’ll be here to help
you through.
Whether you want to speak to our nurses, download our specialist
information or connect with volunteers who have faced what you are
facing now, we can help you feel more in control.
For care, support and information from day one, call us free on 0808 800
6000 or visit breastcancercare.org.uk
###
Contacts
Skechers
Nicola Zachariades
nicolaz@eu.skechers.com
01707
655 955
